Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4H3S9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.644 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.647 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.613 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.459 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.644 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.647 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.621 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.430 |
CLV_PCSK_PC7_1 | 11 | 17 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.511 |
DEG_APCC_DBOX_1 | 106 | 114 | PF00400 | 0.496 |
DEG_APCC_DBOX_1 | 121 | 129 | PF00400 | 0.546 |
DEG_APCC_DBOX_1 | 60 | 68 | PF00400 | 0.520 |
DEG_APCC_DBOX_1 | 71 | 79 | PF00400 | 0.529 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.626 |
DEG_SPOP_SBC_1 | 46 | 50 | PF00917 | 0.588 |
DOC_CYCLIN_RxL_1 | 98 | 109 | PF00134 | 0.512 |
DOC_MAPK_MEF2A_6 | 61 | 69 | PF00069 | 0.523 |
DOC_PP1_RVXF_1 | 99 | 106 | PF00149 | 0.370 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.632 |
LIG_14-3-3_CanoR_1 | 111 | 118 | PF00244 | 0.445 |
LIG_14-3-3_CanoR_1 | 15 | 25 | PF00244 | 0.662 |
LIG_14-3-3_CanoR_1 | 30 | 35 | PF00244 | 0.519 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.487 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.475 |
LIG_LIR_Nem_3 | 57 | 63 | PF02991 | 0.483 |
LIG_NRBOX | 63 | 69 | PF00104 | 0.525 |
LIG_PDZ_Class_2 | 149 | 154 | PF00595 | 0.556 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.541 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.503 |
LIG_SH3_3 | 49 | 55 | PF00018 | 0.602 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.604 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.494 |
MOD_CK1_1 | 45 | 51 | PF00069 | 0.601 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.509 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.547 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.657 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.531 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.499 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.627 |
MOD_LATS_1 | 99 | 105 | PF00433 | 0.485 |
MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.571 |
MOD_PKA_1 | 15 | 21 | PF00069 | 0.643 |
MOD_PKA_1 | 71 | 77 | PF00069 | 0.545 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.631 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.474 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.545 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.591 |
MOD_Plk_1 | 120 | 126 | PF00069 | 0.373 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.359 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.485 |
MOD_SUMO_rev_2 | 85 | 93 | PF00179 | 0.519 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.665 |
TRG_ER_diArg_1 | 122 | 125 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.562 |
TRG_ER_diArg_1 | 82 | 84 | PF00400 | 0.423 |
TRG_NES_CRM1_1 | 108 | 121 | PF08389 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 111 | 115 | PF00026 | 0.580 |
TRG_Pf-PMV_PEXEL_1 | 61 | 66 | PF00026 | 0.518 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC29 | Leptomonas seymouri | 44% | 75% |
A0A3S5H575 | Leishmania donovani | 72% | 97% |
A4HE83 | Leishmania braziliensis | 82% | 100% |
A4HS04 | Leishmania infantum | 71% | 97% |
C9ZY02 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 68% |
E9AJZ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 68% | 97% |
Q9BLQ6 | Leishmania major | 76% | 100% |